A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The adverse metabolic consequences of obesity are best predicted by the quantity of visceral fat. Excess glucocorticoids produce visceral obesity and diabetes, but circulating glucocorticoid levels are normal in typical obesity. Glucocorticoids can be produced locally from inactive 11-keto forms through the enzyme 11β hydroxysteroid dehydrogenase type 1 (11β HSD-1). We created transgenic mice overexpressing 11β HSD-1 selectively in adipose tissue to an extent similar to that found in adipose tissue from obese humans. These mice had increased adipose levels of corticosterone and developed visceral obesity that was exaggerated by a high-fat diet. The mice also exhibited pronounced insulin-resistant diabetes, hyperlipidemia, and, surprisingly, hyperphagia despite hyperleptinemia. Increased adipocyte 11β HSD-1 activity may be a common molecular etiology for visceral obesity and the metabolic syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“other health outcomes associated with better quality of life improved, including sleep apnoea136 and mobility137.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [137]
Citations
Cites
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,237
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Self-citationSubcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Ahima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Self-citationThe Degree of Masculine Differentiation of Obesities
VAGUE, J. (1956) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/4.1.20 · Cited by 1,410
Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
Abel, E. D., Peroni, O., Kim, J. K., Kim, Y.-B., Boss, O., Hadro, E., Minnemann, T., Shulman, G. I., & Kahn, B. B. (2001) · Nature · doi:10.1038/35055575 · Cited by 1,253
Frühbeck, G., Gómez-Ambrosi, J., Muruzábal, F. J., & Burrell, M. A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.6.e827 · Cited by 974
Research works printed but not linked: 5
- 10.1210/jcem.86.3.7453 · doi:10.1210/jcem.86.3.7453 · Paper page
- 10.1101/gad.7.7b.1318 · doi:10.1101/gad.7.7b.1318 · Paper page
- Supplementary data are available on Science Online at www.sciencemag.org/cgi/content/full/294/5549/2166/DC1.
- Strack A. M., Bradbury M. J., Dallman M. F., Am. J. Physiol. 268, R183 (1995).
- 10.1210/jcem.83.5.4951 · doi:10.1210/jcem.83.5.4951 · Paper page
Cited by
Items 501–600 of 1,003
Eixos hormonais na obesidade: causa ou efeito?
Lordelo, R. A., Mancini, M. C., Cercato, C., & Halpern, A. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000100007 · Cited by 68
Zheng, L., Zhai, G., Zhang, J., Wang, L., Ma, Z., Jia, M., & Jia, L. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.07.037 · Cited by 68
Ramis, J. M., Hal, N. L. W. F.-V., Kramer, E., Lladó, I., Bouillaud, F., Palou, A., & Keijer, J. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/pl00012518 · Cited by 68
Stomby, A., Andrew, R., Walker, B. R., & Olsson, T. (2014) · Diabetologia · doi:10.1007/s00125-014-3228-6 · Cited by 68
Campbell, J. E., Király, M. A., Atkinson, D. J., D'souza, A. M., Vranic, M., & Riddell, M. C. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00155.2010 · Cited by 61
“Increased glucocorticoid action in visceral adipose tissue induces the metabolic syndrome through the development of central obesity and dyslipidemia (29).”
BackgroundLocal Androgen Inactivation in Abdominal Visceral Adipose Tissue
Blouin, K., Richard, C., Bélanger, C., Dupont, P., Daris, M., Laberge, P., Luu-The, V., & Tchernof, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030535 · Cited by 59
“(14) recently led to the suggestion that increased expression of 11 -HSD-1 in abdominal adipose tissue may represent a common molecular etiology for visceral obesity and the metabolic syndrome.”
Toneatto, J., Guber, S., Charó, N. L., Susperreguy, S., Schwartz, J., Galigniana, M., & Piwien-Pilipuk, G. (2013) · Journal of Cell Science · doi:10.1242/jcs.125799 · Cited by 55
“Furthermore, adipose tissue-dependent J o u rn a l o f C e ll S c ie n c e amplification of corticosterone production in transgenic mice results in a full metabolic syndrome, including central obesity, insulin resistance and hypertension (Masuzaki et al., 2001).”
BackgroundLiver Is the Site of Splanchnic Cortisol Production in Obese Nondiabetic Humans
Basu, R., Basu, A., Grudzien, M., Jung, P., Jacobson, P., Johnson, M., Singh, R., Sarr, M., & Rizza, R. A. (2009) · Diabetes · doi:10.2337/db08-1079 · Cited by 64
Insulin and Dexamethasone Dynamically Regulate Adipocyte 11β-Hydroxysteroid Dehydrogenase Type 1
Balachandran, A., Guan, H., Sellan, M. E., Uum, S. H. M. V., & Yang, K. (2008) · Endocrinology · doi:10.1210/en.2008-0088 · Cited by 68
Goedecke, J. H., Wake, D. J., Levitt, N. S., Lambert, E. V., Collins, M. R., Morton, N. M., Andrew, R., Seckl, J. R., & Walker, B. R. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02552.x · Cited by 67
Self-citationBlouin, K., Blanchette, S., Richard, C., Dupont, P., Luu-The, V., & Tchernof, A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00312.2004 · Cited by 67
“(23) using cell cultures and transgenic models recently led to the suggestion that increased expression of 11 -HSD-1 in abdominal adipose tissue may represent a common molecular etiology for visceral obesity and the metabolic syndrome.”
BackgroundStimson, R. H., Andrew, R., McAvoy, N. C., Tripathi, D., Hayes, P. C., & Walker, B. R. (2011) · Diabetes · doi:10.2337/db10-0726 · Cited by 67
“For example, transgenic mice selectively overexpressing 11b-HSD1 in adipose tissue develop obesity, insulin resistance, hypertension, and dyslipidemia (3,4).”
BackgroundDietary fructose, salt absorption and hypertension in metabolic syndrome: towards a new paradigm
Soleimani, M. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02167.x · Cited by 67
“One major factor, however, which is essential to the understanding of blood pressure regulation and hypertension, is altered salt absorption in the kidney (O’ Shaughnessy & Karet 2004, Meneton et al. 2005, Haddy 2006, Karppanen & Mervaala 2006).”
BackgroundRu, Y., Chen, X., Wang, J., Guo, L., Lin, Z., Peng, X. X., & Qiu, B. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.11.236 · Cited by 67
Maternal Corticotropin‐Releasing Hormone Levels during Pregnancy and Offspring Adiposity
Gillman, M. W., Rich‐Edwards, J. W., Huh, S., Majzoub, J. A., Oken, E., Taveras, E. M., & Rifas‐Shiman, S. L. (2006) · Obesity · doi:10.1038/oby.2006.189 · Cited by 66
“In animal models, investigators have experimentally increased fetal exposure to glucocorticoids through transgenic models (5), by exogenous administration of dexamethasone (6–8), or by altering maternal diet to decrease the activity of the placental enzyme that deactivates corticosterone (cortisol in the human) to 11-…”
BackgroundInterleukin-1 beta: a potential link between stress and the development of visceral obesity
Speaker, K. J., & Fleshner, M. (2012) · BMC Physiology · doi:10.1186/1472-6793-12-8 · Cited by 66
“Instead, gains in adiposity instigated through transgenic overexpression of the enzyme were predominantly due to hypertrophy of the visceral adipocytes [12] suggesting that the effects of this enzyme are site dependent.”
BackgroundInfluentialInsulin regulation of MCP-1 in human adipose tissue of obese and lean women
Westerbacka, J., Cornér, A., Kolak, M., Makkonen, J., Turpeinen, U., Hamsten, A., Fisher, R. M., & Yki‐Järvinen, H. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00653.2006 · Cited by 66
“Examples of such molecules include TNF- (8, 23), 11 -HSD-1 (10, 20), and PAI-1 (15) and SREBP-1c (17), which continue to respond to insulin in insulin-resistant states.”
BackgroundFructose, Glucocorticoids and Adipose Tissue: Implications for the Metabolic Syndrome
Legeza, B., Marcolongo, P., Gamberucci, A., Varga, V., Bánhegyi, G., Benedetti, A., & Odermatt, A. (2017) · Nutrients · doi:10.3390/nu9050426 · Cited by 66
“Conversely, transgenic 11β-HSD1 KO mice showed reduced hyperglycemia and VAT accumulation and improved insulin sensitivity compared to wild-type mice under conditions of stress and high-fat diet [126].”
BackgroundInfluentialAdamantane sulfone and sulfonamide 11-β-HSD1 Inhibitors
Sorensen, B. K., Winn, M., Rohde, J., Shuai, Q., Wang, J., Fung, S., Monzon, K., Chiou, W. J. H., Stolarik, D. F., Imade, H. M., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.10.008 · Cited by 66
A cellular perspective of adipogenesis transcriptional regulation
Kuri‐Harcuch, W., Velez‐delValle, C., Vazquez‐Sandoval, A., Hernández‐Mosqueira, C., & Fernández-Sánchez, V. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27060 · Cited by 65
“These contrasting dual actions would explain the effects of Dex in vivo because several studies had shown that high glucocorticoid levels could cause metabolic syndrome (Masuzaki et al., 2001) and chronic treatment with glucocorticoid causes Cushing’s syndrome (Christ‐ Crain et al., 2008).”
BackgroundAspectos neuroendócrinos da síndrome metabólica
Matos, A. F. D. G., Moreira, R. O., & Guedes, E. P. (2003) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302003000400013 · Cited by 65
Gelernter‐Yaniv, L., Feng, N., Sebring, N. G., Hochberg, Z., & Yanovski, J. A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802327 · Cited by 65
Bhat, B. G., Hosea, N. A., Fanjul, A. N., Herrera, J., Chapman, J., Thalacker, F. W., Stewart, P. M., & Rejto, P. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.128280 · Cited by 65
“Transgenic mice that overexpress 11 HSD1 specifically in adipose tissue develop visceral obesity that is exacerbated on a high-fat diet, along with other symptoms of the metabolic syndrome, including insulinresistant diabetes, hyperlipidemia, and hypertension (Masuzaki et al., 2001).”
Background1α, 25-Dihydroxyvitamin D and corticosteroid regulate adipocyte nuclear vitamin D receptor
Sun, X., & Zemel, M. B. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.59 · Cited by 64
Subcutaneous Abdominal Adipose Tissue Subcompartments: Potential Role in Rosiglitazone Effects
Walker, G. E., Marzullo, P., Verti, B., Guzzaloni, G., Maestrini, S., Zurleni, F., Liuzzi, A., & Blasio, A. M. D. (2008) · Obesity · doi:10.1038/oby.2008.326 · Cited by 64
“Although the accumulation of VAT has been thought to be exclusively associated with the characteristics of the metabolic syndrome (2,3), there is now evidence to support a role for the accumulation of dSAT in obesity, insulin resistance, and an increased lipolysis (6,10).”
BackgroundSchreyer, S. A., Lystig, T., Vick, C. M., & LeBoeuf, R. C. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.07.010 · Cited by 64
“A variety of mouse strains are available which exhibit obese phenotypes including mice with single gene mutations [8,9], or mice which have been altered by genetic engineering [10,11].”
BackgroundHow Do Glucocorticoids Regulate Lipid Metabolism?
de Guia, R. M., & Herzig, S. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2895-8_6 · Cited by 63
A transgenic model of visceral obesity and the metabolic syndrome
Szidonya, L. K., & Hunyady, L. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00581-7 · Cited by 63
Keller (2006) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831.76.4.172 · Cited by 63
“Transgenic mice with overexpression of this enzyme developed insulin resistance and android obesity [19, 20].”
Background11β-Hydroxysteroid dehydrogenases, cell proliferation and malignancy
Rabbitt, E. H., Gittoes, N. J. L., Stewart, P. M., & Hewison, M. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00224-3 · Cited by 63
Intra-vascular glucocorticoid metabolism as a modulator of vascular structure and function
Hadoke, P. W. F., Macdonald, L. J., Logie, J. J., Small, G. R., Dover, A. R., & Walker, B. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5427-2 · Cited by 63
11β-Hydroxysteroid Dehydrogenase Activity in Hypothalamic Obesity
Tiosano, D., Eisentein, I., Militianu, D., Chrousos, G. P., & Hochberg, Z. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020511 · Cited by 62
Liu, Y., Yan, C., Wang, Y., Nakagawa, Y., Nerio, N., Anghel, A., Lutfy, K., & Friedman, T. C. (2006) · Endocrinology · doi:10.1210/en.2006-0243 · Cited by 62
“This is supported by recent reports demonstrating that activation of 11 -HSD1 expression results in the production of excess tissue glucocorticoids and GR occupancy, leading to the development of insulin resistance and metabolic syndrome (37).”
BackgroundEl tejido graso como modulador endocrino: Cambios hormonales asociados a la obesidad
René Baudrand, B., Eugenio Arteaga, U., & Manuel Moreno, G. (2010) · Revista médica de Chile · doi:10.4067/s0034-98872010001100015 · Cited by 62
Robinson, L. E., & Graham, T. E. (2004) · Canadian Journal of Applied Physiology · doi:10.1139/h04-053 · Cited by 62
“The clustering of CVD risk factors in the metabolic syndrome suggests a common underlying mechanism, with insulin resistance and/or increased abdominal (visceral) obesity frequently suggested as potential etiological factors (Masuzaki et al., 2001; Reaven, 1988).”
BackgroundWalker, B. R. (2007) · Proceedings of the Nutrition Society · doi:10.1017/s002966510700523x · Cited by 54
“Transgenic overexpression of 11b-HSD1 within adipose tissue results in elevated intra-adipose glucocorticoid levels, with associated obesity, hyperglycaemia, dyslipidaemia and hypertension (Masuzaki et al. 2001, 2003).”
BackgroundPPAR ligands: Potential therapies for metabolic syndrome
Akiyama, T. E., Meinke, P. T., & Berger, J. P. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0067-3 · Cited by 62
“For example, it was shown that the overexpression of adipocyte 11β-HSD1 (an enzyme that converts cortisone into its physiologically active form, cortisol) in adipose caused insulin resistance in mice [ 41 ].”
BackgroundObesity and Type 2 Diabetes Do Not Alter Splanchnic Cortisol Production in Humans
Basu, R., Singh, R. J., Basu, A., Chittilapilly, E. G., Johnson, M. C., Toffolo, G., Cobelli, C., & Rizza, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2390 · Cited by 58
Dunford, E. C., & Riddell, M. C. (2016) · Metabolites · doi:10.3390/metabo6040044 · Cited by 61
“Increased 11β-HSD1 expression in adipose tissue in a transgenic rodent model resulted in elevated adipose tissue GC levels, enhanced food intake, and an accumulation of visceral adiposity, along with other features of metabolic syndrome [75].”
BackgroundEmerging themes in idiopathic intracranial hypertension
Grech, O., Mollan, S. P., Wakerley, B. R., Alimajstorovic, Z., Lavery, G. G., & Sinclair, A. J. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10090-4 · Cited by 61
Ignatova, I. D., Kostadinova, R. M., Goldring, C. E., Nawrocki, A. R., Frey, F. J., & Frey, B. M. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90531.2008 · Cited by 61
Genomic and Non-Genomic Actions of Glucocorticoids on Adipose Tissue Lipid Metabolism
Mir, N., Chin, S. A., Riddell, M. C., & Beaudry, J. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168503 · Cited by 61
“As a prereceptor enzyme, 11β-HSD1 functions and converts the inactive GC to its active form, leading to increased GC availability within the cell [73,74].”
BackgroundWake, D. J., Homer, N. Z. M., Andrew, R., & Walker, B. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0819 · Cited by 57
“of 11HSD1 within adipose tissue (6) or liver (7) results in local”
BackgroundGenetic analysis of 22 candidate genes for hypertension in the Japanese population
Iwai, N., Tago, N., Yasui, N., Kokubo, Y., Inamoto, N., Tomoike, H., & Shioji, K. (2004) · Journal of Hypertension · doi:10.1097/00004872-200406000-00012 · Cited by 61
Thompson, A., Han, V. K. M., & Yang, K. (2002) · Biology of Reproduction · doi:10.1095/biolreprod.102.005488 · Cited by 58
“Given the putative role of placental 11b-HSD in the control of not only transplacental passage of maternal glucocorticoid to the fetus but also local glucocorticoid action [12], coupled with the tremendous utility of the mouse model in unraveling the precise role of 11b-HSD1 and 11bHSD2 in normal physiology [16, 17] a…”
BackgroundAnuka, E., Gal, M., Stocco, D. M., & Orly, J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.02.003 · Cited by 60
Morante, J. J. H., Gómez‐Santos, C., Milagro, F. I., Campión, J., Martínez, J. A., Zamora, S., & Garaulet, M. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.4 · Cited by 60
Berthiaume, M., Laplante, M., Festuccia, W. T., Cianflone, K., Turcotte, L. P., Joanisse, D. R., Olivecrona, G., Thieringer, R., & Deshaies, Y. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00276.2007 · Cited by 58
Sebert, S. P., Hyatt, M. A., Chan, L. L. Y., Yiallourides, M., Fainberg, H. P., Patel, N. N., Sharkey, D., Stephenson, T. J., Rhind, S., Bell, R. C., et al. (2009) · Reproduction · doi:10.1530/rep-09-0173 · Cited by 60
Iwasaki, Y., Takayasu, S., Nishiyama, M., Tsugita, M., Taguchi, T., Asai, M., Yoshida, M., Kambayashi, M., & Hashimoto, K. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.01.012 · Cited by 60
Diabetes mellitus in a domesticated Spanish Mustang
Johnson, P. J., Scotty, N. C., Wiedmeyer, C. E., Messer, N. T., & Kreeger, J. M. (2005) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2005.226.584 · Cited by 60
“Omental adipocytes also possess the enzyme 11β-hydroxysteroid dehydrogenase-1, which converts circulating inactive cortisone to the physiologically active glucocorticoid cortisol.(23,24) Many adipose-derived endocrine signals, including cortisol, directly inhibit the action of insulin and cause insulin resistance.”
BackgroundWalker, B. R., & Seckl, J. R. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.6.771 · Cited by 57
“Overexpression of 11HSD1 within white adipose tissue, using the AP2 promoter/enhancer, resulted in an ∼ 3-fold increase in 11HSD1 activity in fat, producing a striking phenotype [45].”
Self-citationInsulin resistance induced by hydrocortisone is increased in patients with abdominal obesity
Darmon, P., Dadoun, F., Boullu-Ciocca, S., Grino, M., Alessi, M.-C., & Dutour, A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00654.2005 · Cited by 59
“Oppositely, transgenic mice with a selective overexpression of 11 -HSD-1 in adipose tissue have increased corticosterone levels in adipose tissue and develop metabolic disturbances that faithfully replicate the metabolic syndrome, suggesting that increased 11 -HSD-1 activity in adipose tissue may represent a molecular…”
BackgroundThe Stress Axis in Obesity and Diabetes Mellitus: An Update
Gianotti, L., Belcastro, S., D’Agnano, S., & Tassone, F. (2021) · Endocrines · doi:10.3390/endocrines2030031 · Cited by 59
“On the contrary, transgenic mice selectively overexpressing 11β-HSD-1 in adipose tissue (AT) developed visceral OB, pronounced insulin-resistant diabetes and hyperlipidemia [30].”
BackgroundPriego, T., Sánchez, J., Palou, A., & Picó, C. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.18 · Cited by 59
Daulatzai, M. A. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9407-2 · Cited by 59
“For example, 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) that increases in obesity may induce cortisol production (and may also upregulate differentiation of preadipocytes into adipocytes) (Masuzaki et al. 2001).”
BackgroundSun, X., Morris, K. L., & Zemel, M. B. (2007) · Lifestyle Genomics · doi:10.1159/000109873 · Cited by 59
“Excessive central fat deposition in obesity may result from the greater capacity for regeneration of active glucocorticoids in the visceral fat depot [ , , ,”
BackgroundGuo, C., Li, C., Myatt, L., Nathanielsz, P. W., & Sun, K. (2013) · Diabetes · doi:10.2337/db12-0561 · Cited by 57
“A key role for 11b-HSD1 in metabolic syndrome is supported by findings that 11bHSD1 mice are protected from developing metabolic syndrome (18,19), whereas selective overexpression of 11b-HSD1 in adipose or liver tissue, the two major tissues expressing 11b-HSD1 in the body, leads to a metabolic syndrome phenotype (20,…”
BackgroundMyricetin Exerts Anti-Obesity Effects through Upregulation of SIRT3 in Adipose Tissue
Akindehin, S., Jung, Y.-S., Kim, S.-N., Son, Y.-H., Lee, I., Seong, J. K., Jeong, H. W., & Lee, Y.-H. (2018) · Nutrients · doi:10.3390/nu10121962 · Cited by 59
“For the HFD experiments, 60% fat diet [16,17] (Research Diets # D12492, protein: 20% kcal, fat: 60% kcal, carbohydrate: 20% kcal, energy density: 5.”
Gout, J., Tirard, J., Thevenon, C., Riou, J. P., Bégeot, M., & Naville, D. (2006) · Biochimie · doi:10.1016/j.biochi.2006.05.020 · Cited by 59
Cyp11b1 Null Mouse, a Model of Congenital Adrenal Hyperplasia
Mullins, L. J., Peter, A., Wrobel, N., McNeilly, J. R., McNeilly, A. S., Al-Dujaili, E. A. S., Brownstein, D. G., Mullins, J. J., & Kenyon, C. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805081200 · Cited by 51
Self-citationFotsch, C. H., & Wang, M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800369f · Cited by 59
Modulation of glucocorticoid action and the treatment of type-2 diabetes
Tomlinson, J., & Stewart, P. M. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.07.003 · Cited by 59
Impact of the GH-cortisol ratio on the age-dependent changes in body composition
Nass, R., & Thorner, M. O. (2002) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(02)00022-9 · Cited by 58
Yuan, X., Li, H., Bai, H., Su, Z., Xiang, Q., Wang, C., Zhao, B., Zhang, Y., Zhang, Q., Chu, Y., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.012 · Cited by 58
“Glucocorticoids increase glucose output in the liver, induce fat accumulation, dampen glucose-dependent insulin sensitivity in the adipose tissue, thus increasing the risks of metabolic syndrome [1].”
Background11β-Hydroxysteroid dehydrogenase 1: Regeneration of active glucocorticoids is only part of the story
Odermatt, A., & Klusoňová, P. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.08.011 · Cited by 59
Effect of exercise training on adipocyte-size-dependent expression of leptin and adiponectin
Miyazaki, S., Izawa, T., Ogasawara, J., Sakurai, T., Nomura, S., Kizaki, T., Ohno, H., & Komabayashi, T. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.03.004 · Cited by 58
“…levels of corticosterone, which are due to enhanced activity of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) in transgenic mice overexpressing 11β-HSD1, have been thought to induce visceral obesity and promote adipogenesis and hyperlipidemia (Masuzaki et al. 2001; Livingston et al. 2000).”
BackgroundMatsuda, M., & Shimomura, I. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0001 · Cited by 58
“Fat-specific overexpression of 11βHSD1 shows a phenotype presenting abdominal obesity, hypertension, and insulin resistance [112].”
BackgroundPeixoto, R. D. S., Turban, S., Battle, J. H., Chapman, K. E., Seckl, J. R., & Morton, N. M. (2008) · Endocrinology · doi:10.1210/en.2007-1028 · Cited by 58
Self-citationSu, X., Lawrence, H. R., Ganeshapillai, D., Cruttenden, A., Purohit, A., Reed, M. J., Vicker, N., & Potter, B. V. L. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.06.008 · Cited by 58
Ishii, T., Masuzaki, H., Tanaka, T., Arai, N., Yasue, S., Kobayashi, N., Tomita, T., Noguchi, M., Fujikura, J., Ebihara, K., et al. (2007) · FEBS Letters · doi:10.1016/j.febslet.2006.11.032 · Cited by 51
“It has been shown that matured adipocytes abundantly express 11b-HSD1 which is critically involved in dysfunction of adipose tissue [2,5].”
BackgroundSelf-citationEmerging concepts in the pathophysiology and treatment of obesity-associated hypertension
Engeli, S., & Sharma, A. M. (2002) · Current Opinion in Cardiology · doi:10.1097/00001573-200207000-00006 · Cited by 58
Hou, M., Liu, Y., Zhu, L., Sun, B., Guo, M., Burén, J., & Li, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025726 · Cited by 57
“Adipose- or liver-specific 11b-HSD1 overexpression in transgenic mice exhibit elevated intra-adipose and portal corticosterone levels, abdominal obesity, dyslipidemia, insulin resistance, and hypertension [10,11].”
BackgroundIs There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?
Das, U. N. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00182 · Cited by 57
“Transgenic mice over expressing adipose tissue 11 β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1) developed abdominal obesity and showed several features of type 2 DM, such as insulin resistance, hyperlipidemia, and hyperphagia (206), which led to the suggestion that type 2 DM could be termed as “localized Cushing’s…”
Background11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome
Bailey, M. A. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0797-z · Cited by 57
Berthiaume, M., Sell, H., Lalonde, J., Gélinas, Y., Tchernof, A., Richard, D., & Deshaies, Y. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00339.2004 · Cited by 57
“This is vividly illustrated by the development of visceral obesity and the metabolic syndrome in mice overexpressing adipose 11 HSD1 (32) and by the lack thereof in response to high-fat feeding in mice with 11 HSD1 gene invalidation (26, 36, 37).”
BackgroundRangwala, S. M., & Lazar, M. A. (2002) · Science Signaling · doi:10.1126/stke.2002.121.pe9 · Cited by 57
Gu, X., Dragovic, J., Koo, G. C., Koprak, S., LeGrand, C. B., Mundt, S. S., Shah, K., Springer, M. S., Tan, E. Y., Thieringer, R., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.08.052 · Cited by 57
Wirtz, P. H., Ehlert, U., Emini, L., & Suter, T. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.05.002 · Cited by 56
“In a very elegant animal study, the development of obesity was related to overexpression of 11b-hydroxysteroid dehydrogenase (11-b-HSD-1) (Masuzaki et al., 2001).”
BackgroundAdipokines and Cardiovascular Risk in Cushing’s Syndrome
Valassi, E., Biller, B. M. K., Klibanski, A., & Misra, M. (2012) · Neuroendocrinology · doi:10.1159/000330416 · Cited by 53
Increased Adiposity in Annexin A1-Deficient Mice
Akasheh, R. T., Pini, M., Pang, J., & Fantuzzi, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082608 · Cited by 56
“Since over-expression of 11bHSD1 leads to increased adiposity, elevated leptin levels, insulin resistance and hyperlipidemia [26], while a selective 11bHSD1 inhibitor prevents adipogenesis [31], alteration of this pathway by ANXA1 represents an additional potential mechanism to explain the increased adiposity of KOHFD…”
BackgroundBarth, S., Klein, P., Horbach, T., Dötsch, J., Rauh, M., Rascher, W., & Knerr, I. (2010) · Obesity Facts · doi:10.1159/000319508 · Cited by 51
Energetic stress: The reciprocal relationship between energy availability and the stress response
Harrell, C. S., Gillespie, C. F., & Neigh, G. N. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.10.009 · Cited by 57
“While obesity is associated with a reduction in liver 11βHSD1, it is linked with an increase in adipose tissue 11βHSD1 in both humans (Rask et al., 2002) and animal models (Masuzaki et al., 2001).”
Ren, Z., Li, J., Xu, N., Zhang, J., Song, X., Wang, X., Gao, Z., Jing, H., Li, S., Zhang, C., et al. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.08.009 · Cited by 56
Classen-Houben, D., Schuster, D., Cunha, T. D., Odermatt, A., Wolber, G., Jordis, U., & Kueenburg, B. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.01.009 · Cited by 56
Campbell, J. E., Fediuc, S., Hawke, T. J., & Riddell, M. C. (2009) · Metabolism · doi:10.1016/j.metabol.2009.01.002 · Cited by 57
“002 specific overexpression of 11βHSD1 results in a dramatic increase in intracellular concentrations of active GCs despite normal plasma concentrations [3].”
BackgroundResultInfluentialOpposite Effects of Background Genotype on Muscle and Liver Insulin Sensitivity of Lipoatrophic Mice
Colombo, C., Haluzik, M., Cutson, J. J., Dietz, K. R., Marcus-Samuels, B., Vinson, C., Gavrilova, O., & Reitman, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207665200 · Cited by 51
Sutinen, J., Kannisto, K., Korsheninnikova, E., Nyman, T., Ehrenborg, E., Andrew, R., Wake, D. J., Hamsten, A., Walker, B. R., & Yki-J�rvinen, H. (2004) · Diabetologia · doi:10.1007/s00125-004-1508-2 · Cited by 56
Correia-Branco, A., Keating, E., & Martel, F. (2015) · Reproductive Sciences · doi:10.1177/1933719114542012 · Cited by 55
“More specifically, transgenic mice that selectively overexpress adipose tissue 11b-HSD1 have increased adipose tissue levels of corticosterone, develop visceral obesity, and are glucose intolerant.(80) On the contrary, homozygous 11b-HSD1 / knockout mice are protected from features of MetS and obesity, that is, they a…”
BackgroundBoscaro, M., Giacchetti, G., & Ronconi, V. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06597.x · Cited by 55
Biedasek, K., Andres, J., Mai, K., Adams, S., Spuler, S., Fielitz, J., & Spranger, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016674 · Cited by 49
“Transgenic mice over-expressing 11betaHSD1 specifically in adipose tissue gained weight and developed insulin resistance and dyslipidemia [4].”
BackgroundGambineri, A., Tomassoni, F., Munarini, A., Stimson, R. H., Mioni, R., Pagotto, U., Chapman, K. E., Andrew, R., Mantovani, V., Pasquali, R., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0091 · Cited by 55
Adipocyte glucocorticoid receptor has a minor contribution in adipose tissue growth
Desarzens, S., & Faresse, N. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0121 · Cited by 55
Frick, C., Atanasov, A. G., Arnold, P., Ozols, J., & Odermatt, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313666200 · Cited by 55
Johansson, L., Fotsch, C., Bartberger, M. D., Castro, V. M., Chen, M., Emery, M., Gustafsson, S., Hale, C., Hickman, D., Homan, E., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701551j · Cited by 49
Non-alcoholic fatty liver disease: From insulin resistance to mitochondrial dysfunction
Herruzo, J. A. S., Ruiz, I. G., Carreras, M. P., & Muñoz-Yagüe, M. T. (2006) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082006001100006 · Cited by 55
“Visceral fat has been shown to be particularly resistant to insulin activity (78), and is thus more easily hydrolyzed.”
BackgroundRollinger, J. M., Kratschmar, D. V., Schuster, D., Pfisterer, P. H., Gumy, C., Aubry, E. M., Brandstötter, S., Stuppner, H., Wolber, G., & Odermatt, A. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.01.010 · Cited by 55
Abreu, S., Santos, R., Moreira, C. M. M., Santos, P. C., Mota, J. A. P. S., & Moreira, P. A. M. (2013) · Public Health Nutrition · doi:10.1017/s1368980013001948 · Cited by 55
“It has described that visceral adipose tissue has greater amounts of 11-b-hydroxysteroid dehydrogenase type 1((48)), which is over-expressed in vitro in those with central adiposity((49)).”
BackgroundAssociation of regional body fat with metabolic risks in Chinese women
Fu, X., Song, A., Zhou, Y., Ma, X., Jiao, J., Yang, M., & Zhu, S. (2013) · Public Health Nutrition · doi:10.1017/s1368980013002668 · Cited by 55
Woods, C. P., Corrigan, M., Gathercole, L., TAYLOR, A. E. R., Hughes, B. A., Gaoatswe, G., Manolopoulos, K. N., Hogan, A. E., O’Connell, J., Stewart, P. M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4120 · Cited by 55
“Transgenic mice, with overexpression of 11 -HSD1 specifically in adipose tissue, gain more weight and develop metabolic complications compared to the wild type (47).”
Background
Metadata
- Authors
- Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- University of Edinburgh (GB)
- Corresponding author
- Flier, Jeffrey S.
- Venue
- Science
- Published
- 2001-12-07
- Volume
- 294
- Issue
- 5549
- Pages
- 2166-2170
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2117268230
- Cited by
- 1,766
- References
- 34
- Citations by year
- 2026: 9 · 2025: 21 · 2024: 30 · 2023: 19 · 2022: 23 · 2021: 44 · 2020: 34 · 2019: 39 · 2018: 54 · 2017: 52 · 2016: 63 · 2015: 74 · 2014: 72 · 2013: 106 · 2012: 98
- FWCI
- 71.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- visceral obesity, metabolic syndrome, 11β-hydroxysteroid dehydrogenase type 1, glucocorticoids, corticosterone, adipose tissue, transgenic mice, insulin resistance, diabetes mellitus, hyperlipidemia, hyperphagia, leptin, high-fat diet
- MeSH terms
- Abdomen, Adipose Tissue, Animals, Body Composition, Corticosterone, Dietary Fats, Disease Models, Animal, Eating, Humans, Hydroxysteroid Dehydrogenases, Hyperglycemia, Hyperinsulinism, Insulin Resistance, Lipids, Lipoprotein Lipase, Male, Mice, Transgenic, Obesity, Receptors, Glucocorticoid, Viscera, Weight Gain, Adipocytes, Gene Targeting, Leptin, Metabolic Syndrome, 11-beta-Hydroxysteroid Dehydrogenase Type 1, Cell Size, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.